Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Nuclear imaging equipment market analysis: explore PET, SPECT systems, installed base, market trends and forecasts to 2036 with GlobalData insights.
Understand the Global Nuclear Imaging Equipment Market
Nuclear imaging plays a critical role in modern diagnostics, enabling precise evaluation of internal body functions and diseases.
This market model provides a detailed view of nuclear imaging equipment, including PET and SPECT systems, along with advanced hybrid technologies such as PET/CT, PET/MRI, SPECT/CT, and SPECT/MRI.
Using radioactive tracers, these systems generate detailed images that support the diagnosis of cancers, cardiac, neurological, and other conditions.
As a result, demand for accurate, non-invasive diagnostic tools continues to shape market growth and innovation.
Report Value Proposition – Why This Matters for You
This report goes beyond traditional market sizing. It provides a comprehensive view of both quantitative performance and qualitative market dynamics.
You can use it to:
- Analyze installed base, sales volumes, and pricing trends
- Track market size and segment-level forecasts to 2036
- Understand competitive positioning and company share
- Evaluate regulatory, reimbursement, and market access dynamics
- Support strategic planning and investment decisions
In addition, the model is powered by GlobalData’s proprietary datasets and analyst insights.
Key Insights in Nuclear Imaging Market Trends
Nuclear imaging technologies continue to evolve, with hybrid systems combining multiple imaging modalities gaining traction.
PET and SPECT systems remain central to diagnostic imaging, supported by advancements in radiopharmaceuticals and imaging capabilities.
Market dynamics are shaped by regulatory frameworks, reimbursement policies, and healthcare system structures across countries.
At the same time, demand for early and accurate diagnosis is reinforcing the role of nuclear imaging across multiple therapeutic areas.

Scope
What You Will Learn
The report provides a structured view of the nuclear imaging equipment market, including:
- Market size, segmentation, and forecasts to 2036
- Installed base and device sales trends
- Technology landscape across PET, SPECT, and hybrid systems
- Regulatory, reimbursement, and market access insights
- Competitive landscape and company share analysis
Target Buyers for This Report
This report is designed for decision-makers across healthcare and medtech sectors:
- Medical device manufacturers
- Healthcare providers and procurement teams
- Investors and private equity firms
- Strategy and market intelligence professionals
If you are evaluating opportunities in diagnostic imaging, this report will support your decisions.
How Companies Use This Report
- Medtech companies and device manufacturers
Track market trends and identify growth opportunities - Healthcare providers and procurement teams
Evaluate equipment adoption and supplier landscape - Investors and private equity firms
Assess market potential and competitive positioning - Strategy and market intelligence teams
Support long-term planning and investment decisions
As a result, you can make informed decisions across the healthcare value chain.
Reasons to Buy
Competitive Landscape and Market Coverage
The report provides a detailed view of the competitive environment, covering leading players such as GE HealthCare Technologies Inc, Siemens Healthineers AG, Shanghai United Imaging Healthcare Co Ltd, Canon Medical Systems Corp, and Philips Healthcare Informatics Inc.
It spans 39 countries, delivering global, regional, and country-level insights supported by fully sourced data models and analyst commentary.
Built on Trusted Data and Expert Analysis
This report is built on GlobalData’s robust research methodology and multi-source data integration.
- Incorporates demand- and supply-side primary research
- Leverages real-world data including hospital and procurement databases
- Supported by analyst insights and qualitative context
Therefore, you can rely on the insights for accurate and strategic decision-making.
Act Now to Capitalize on Diagnostic Imaging Growth
Nuclear imaging remains central to modern diagnostics, with technology advancements and rising demand shaping the market.
This report helps you understand how the market is evolving across technologies, regions, and competitive players.
Therefore, if you are planning investment, expansion, or product strategy, now is the time to act.
Siemens Healthineers AG
Shanghai United Imaging Healthcare Co Ltd
Canon Medical Systems Corp
Philips Healthcare Informatics Inc
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
